Evidence map›Paper›PMID 42060301›Full record

ArticleJAMA network open2026

Family Disclosure of a Cancer Diagnosis to Patients.

Chenglei Hu, Hongyu Zhao, Yanhong Yan, Fang Fang, Chen Chen, Ping Yu, Jinrong Wei, Ericka Waidley, Josephine Hegarty, Pingting Zhu

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chenglei HuSchool of Nursing, Yangzhou University, Yangzhou, China.
Hongyu ZhaoSchool of Nursing, Yangzhou University, Yangzhou, China.
Yanhong YanDepartment of Nursing, Jiangsu Province Hospital, Nanjing, China.
Fang FangSchool of Nursing, Yangzhou University, Yangzhou, China.
Chen ChenDepartment of Cardiac Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Ping YuSchool of Nursing, Yangzhou University, Yangzhou, China.
Jinrong WeiDepartment of Nursing, Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, China.
Ericka WaidleyLinfield-Good Samaritan School of Nursing, Linfield College, Portland, Oregon.
Josephine HegartySchool of Nursing and Midwifery, Brookfield Health Sciences Complex, University College Cork, Cork, Ireland.
Pingting ZhuSchool of Nursing, Yangzhou University, Yangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: In Chinese culture, families often take primary control over disclosing a cancer diagnosis, balancing a desire to protect patients' emotional well-being with respect for their right to know. This dynamic can influence patients' psychological health and overall treatment experience. Objective: To examine decision-making dynamics, communication strategies, and power structures involved in how Chinese families balance the delivery of information with patients' psychological protection when disclosing a cancer diagnosis. Design, Setting, and Participants: This qualitative study used semistructured interviews with family members of adult patients with cancer in China. Purposive sampling ensured diversity in sex, age, and relationship to patients. Data collection and analysis were conducted simultaneously from June 1, 2024, to July 31, 2025, using thematic analysis. Main Outcomes and Measures: Key themes related to how families managed cancer diagnosis disclosure. Interviews elicited family members' expectations, decision-making processes, and strategies for balancing protection and patient autonomy. Results: A total of 41 family members were interviewed (median [range] age, 38 [21-56] years; 24 females [58.5%]). Four themes were identified: (1) family negotiation and decision-making on diagnosis disclosure, (2) conflict and collaboration between families and health care professionals, (3) implementation of family-led initial disclosure strategies, and (4) dynamic adjustment of disclosure strategies with treatment progression. These themes illustrated how families continually balanced protection and autonomy in evolving clinical circumstances. Conclusions and Relevance: In this qualitative study, cancer diagnosis disclosure within Chinese families unfolded as a culturally embedded and fluid process, requiring ongoing negotiation and adjustment among family members. Given the continued prominence of families in medical decision-making in China, future interventions should aim to bridge the gap between family involvement in care and patient autonomy. While offering necessary family support, these strategies should also aim to steer the disclosure model toward one that elevates and protects the patient's voice, thereby moving closer to internationally accepted ethical standards.

Indexed as

FamilyNeoplasmsTruth DisclosureAdultChinaDecision MakingFemaleHumansMaleMiddle AgedQualitative ResearchYoung Adult

Identifiers

PMID42060301
PMCPMC13133687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.